9530 PSDV
— —
At closeJun 28, 2019, 6:07 PM EDT
Day range unavailable
52-week range unavailable
News
businesswire.com pSivida Corp Announces Fourth Quarter and Fiscal Year 2015 Financial
Results Release Date and Conference Call Information WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that its…
businesswire.com pSivida Corp. Announces Third Quarter Fiscal Year 2015 Financial
Results Release Date and Conference Call Information WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that its…
businesswire.com pSivida Corp. Announces Second Quarter Fiscal Year 2015 Financial
Results Release Date and Conference Call Information WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that its…
businesswire.com pSivida Corp. Announces First Quarter Fiscal 2015 Financial Results
Release Date and Conference Call Information WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its…
businesswire.com pSivida Corp Announces Fourth Quarter and Fiscal Year 2014 Financial
Results Release Date and Conference Call Information WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its…
businesswire.com pSivida Corp Announces Third Quarter 2014 Financial Results Release
Date and Conference Call Information WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its…
businesswire.com pSivida Corp Announces Second Quarter 2014 Financial Results Release
Date and Conference Call Information WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its…
